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A STUDY ON CHLAMYDIA TRACHOMAT8S INFECTION IN PREGNANCY IN 
HOSPITAL KOTA BHARU 
K Seman 1, SRJ Noor1, NAA Ghaffar1, WZ)fl/ Yusuff2, ZA Hanafiah2 , N Maning3 
1Q&G Dept,HUSM; 20&G Dept, Hospital Kota Bharu; 3Microbiology Dept, Hospital Kota 
Bharu, Kelantan, Malaysia. 
Objectives: (1) To determine the prevalence of genital Chlamydia trachomatis infection . 
in pregnancy among the attendees of Antenatal Clinic of Hospital Kota Bharu (HKB), 
Kelantan; (2) To determine the clearance rate of chlamydia! infection with one week 
course of Erythromycin Stearate 500mg six hourly. 
Introduction: Chlamydia trachomatis infection is the most common sexually transmitted 
disease worldwide. In pregnancy, it has been associated with morbidity for both the 
mother and the newborn. . 
!IJ1ethodology: Prospective cross sectional study. 440 pregnant women (age range 17 to 
48 years old), in the first to third trimester, attending the antenatal clinic of Hospital Kota 
Bharu, Kelantan were tested fo.r Chlamydia trachomatis. Endocervical swabs were 
collected for Chlamydia trachomatis diagnosis by Direct Fluorescence antibody (DFA) 
technique. The women were followed up as routine and were advised to deliver in HKB. 
Results: Out of 440 pregnant women tested, 96% were Malays and four were tested 
positive for Chlamydia trachomatis, giving the prevalence rate of 0.9%. There were no 
statistically differences in the gravidity, parity, socioeconomic status, educational level, 
history of prematurity or stillbirth or abortion, between the positive and negative group. All 
of the four women with positive results had no symptoms and they were retested after 
treatment and all of them were cleared. However, small number of patients precludes 
further statistical analysis. 
Conclusion: Due to low prevalence of genital Chlamydia trachomatis infection in 
antenatal population of HKB, universal screening is not necessary. 
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4) (a) Penemuan Projek/Abstrak 
{Perlu disediakan makluman di antara 1 00 - 200 perkataan di dalam Bahasa Malaysia dan Bahasa 
lnggeris. lni kemudiannya akan dimuatkan ke dalam Laporan Tahunan Sahagian Penyelidikan & 
Pembangunan sebagai satu cara untuk menyampalkan dapatan projek tuan/puan kepada pihak 
Universiti). 
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(b) Senaraikan Kata Kunci yang digunakan di dalam abstrak: 
Bahasa Malaysia 
WANITA MENGANDUNG 
·········································· UJIAN SARINGAN 
·········································· 
CHLAMYDIAL 
·········································· 
ERYTHROMYCIN 
·········································· 
KEBERKESANAN KOS 
·········································· 
·········································· 
·········································· 
·········································· 
·········································· 
·········································· 
Bahasa lnggeris 
PREGNANT WOMEN 
SCREENING 
CHLAMYDIAL 
ERYTHROMYCIN 
COST EFFECTIVENESS 
................................................... 
5) Output Dan Faedah Projek 
(a) Penerbitan (termasuk laporan/kertas seminar) (Sila nyatakan jenis, tajuk, pengarang, tahun terbitan dan di mana telah diterbit/dibentangkan). 
PENYERTAAN 'PAPER PRESENTATION' DI PERJUMPAAN PERSATUAN OBSTETRIKS DAN 
··································································································································· GINEKOLOGI MALAYSIA' DI KOTA KINABALU, SABAH PADA TAHUN 2003 
··································································································································· 
··································································································································· 
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··································································································································· 
................ ,..,. ................ ,. ..... ,. ... ,. ............ ,. ......... ,. .... ,. ............ ,. ........................................... . 
.............................................................................................................. ,. ................... . 
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(b) Faedah-Faedah Lain Seperti Perkembangan Produk, Prospek Komersialisasi 
Dan Pendaftaran Paten. 
(Jika ada dan jika perlu, sila guna kertas berasingan) 
································································································································· 
································································································································· 
................................................................................................................................. 
································································································································· 
································································································································· 
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································································································································· 
(c) Latihan Gunatenaga Manusia 
DR.KHAI RIAH SEMAN - pel ajar ijazah klinikal 
i) Pelajar Siswazah: ................................................................ . 
Lanjutan perubatan perbidanan dan sakit puan. 
······························································································ 
ii) Pelajar Prasiswazah: 
····························································· 
····························································································· 
····························································································· 
····························································································· 
iii) Lain-Lain: 
········································································ 
······························································································ 
······························································································ 
······························································································ 
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6. Peralatan Yang Telah Dibeli: 
UJIAN PENGESAN SARINGAN UNTUK CHLAMYDIAL ie DIRECT FLUORESCENCE 
··· ····· ···· ·········· ··············· ····························· ·· ···· ·· ········ ·· ··· ·················· ············ 
ANTIGEN DETECTION TECHNIQUE 
··········· ···· ·········· ·············· ···· ·· ·············· ················ ·········································· 
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Abstrak 
Jang,kil<111 ( 'hlomydia trachoma/is adalah jangkitan bacteria yang, paling kcrap dan 
mcrupakan penyakit kclamin paling tinggi kadarnya di dunia pada masa kini . Pcrtubuhan 
Kcsihatan Sedunia (WHO) menjangkakan sebanyak 89 jut a kes baru bagi jangkitan 
chlamydia berlaku pada tahun 1995 menunjukkan kadar jangkitan ini yang meningkat. 
Untuk wanita menganclung, jangkitan chlamydia ini memberi kesan ke atas kes ihCltC'ln ibu 
dan bayi yang dikandung. 
( )hjekt[( Pertama; untuk mengctahui kadar jangkitan kt11nan ( 'hlomydia troclwmutis di 
kalangan wanita mengandung yang datang kc klinik ibu mengandung eli Hospital Kota 
Bhant, Kelantan . Kedua; untuk rnengetahui kadar keberkesanan ubat erythromyc in stearate 
500rng seti ap enam jam yang diberi selama satu minggu dalam mengubati jangkitan in i. 
Koedah: Seramai 440 wanita mengandung (berusia di antara 17 dan 48 tahun) , dari 
trimester satu hingga trimester tiga, yang menghadiri klinik ibu mengandung di Hospital 
Kota Bharu Kelantan, disaring untuk jangk itan ktunan Chlamydia trachomotis. Sapuan dari 
endocervik diambil untuk diuji menggunakan teknik Direct Fluorescent Antigen. 
Keputusan: Daripada 440 wanita mengandung yang diuji, seramat empat orang disahkan 
mengalami jangkitan ini, memberikan kadar jangkitan sebanyak 0.9%. Pcrbandingan 
statistik tidak dapat dil akukan di antara mereka yang positif dan negatil' dari segi umur, 
bilangan kandungan, bilangan anak, status sosioekonomi, tahap pcrsekolahan, dan juga 
scjarah kclahiran pramatang atau kcguguran, di scbabkan bilangan mcrcka yang positif 
adalah kecil. Semua cmpat wanita yang dijangkiti kuman ini tidak mcmpunyai sebarang 
simptom, mcreka dibcri rawatan dan llJian selcpas rawatan menunjukkan mereka sembuh 
sepenuhnya. Walaubagaimanapun, bilangan mcrcka yang scdikit menghalang analis is 
statistik setcrusnya. 
Konk/usi: Oisebabkan kadar jangkitan ( ·.trachomatis di kalangan wan ita mengandung di 
Hospital Kota Bharu rendah, maka sanngan universal adalah tidak kos-efektif, dan ujian 
dia~:,mostik berdasarkan simptom klinikal adalah tidak mencukupi. 
XI 
ABSTRACTS 
Chlamydia trachoma/is infection is the most common curable bacterial infection, and is 
110w the most common sexually transmitted disease worldwide. World Health Organisation 
figures estimated that 89 million new cases or genital chlamydia! infections occurred in 
1995, highlighting the worldwide prevalence or infections and the economic hurden on 
healthcare delivery. For pregnant women, this infection has been associated with morbidity 
tor both the mother and the newborn. 
()~jectives: This study was undertaken with the objecti ves to detem1ine the prevalence of 
genital Chlamydia trachoma/is infection in pregnancy among the attendees of Antenatal 
Clinic of Hospi tal Kola Bharu, Kelantan so as to ascertain whether universa l screening is 
needed or not. The other objective is to observe the effectiveness of treatment of 
chlamydia! infection with one-week course of erythromycin stearate 500mg qid. 
Methodology: 440 pregnant women (age range 17 to 48 years old), in the first to third 
trimester, attending the antenatal clinic of Hospital Kota Bhanr, Kelantan were tested for 
Chlamydia trachomatis. Endocervical swabs were collected for Chlamydia trachomatis 
diagnosis by Direct fluorescence antigen detection (DFA) technique. 
!?esults: Out of 440 tested women, four were positive, giving the prevalence rate of 0 .9%. 
No valid statistical analysis can be made with regards to the age, gravidity, parity, 
socioeconomic status, education level, history o r prematurity or stillbirth or abortion 
:X II 
between the positive and negative group because of the sn1all nun1ber of wo1nen with 
positive results. All the four won1en with positive results were retested after treatn1ent and 
all of then1 were cleared. However, small nun1ber of patients again, precludes further 
statistical analysis. 
Conclusion: As the prevalence rate of genital Chlamydia trachomatis infection in antenatal 
populat~on of Hospital Kota Bharu_i~-v~~--low, there is no need for universal screening to 
detect this infection. All of the women with positive chlamydial tests were asymptomatic. 
Therefore diagnostic testing based on clinical findings is unreliable. 
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Abstrak 
Jangkil<ln ( Namydia trachoma/is adalah jangkitan bacteria yang paling kcrap dan 
·~ 
mcrupakan penyakit kelamin paling tinggi kadamya di dunia pada masa kini . J>crtubuhan 
Kcsihatan Sedunia (WHO) menjangkakan sebanyak 89 juta kes baru bagi j<ll_lgkitan 
. ~ ':l . ,, . 
chlamydia bcrlaku pada tahun 1995 menunjukk_an kadar jangkitan ini yang nH.:nin9kilt. 
Untuk .wanita menganclung, j angkitan chlamydia ini memberi kcsan ke alas kcsihatan ibu 
dan .bayi yang dikandung. 
( )hjekll/ Pcrtama: untuk mcngctahui kadar jangkitan kuman ( No111ydiu rruclw11wlls di 
ka lan g.a n wanita mengandung yang datang kc klinik ibu mengandung eli ll ospi tal Kota 
l)haru, Kc lantan. Kedua : untuk mcngetahui kadar keberkesanan ubat erythromyc in stearate 
500mg sc ti Ci p cnamjam yang dibcri sclama satu minggu dalammcngubati jangkitan ini 
1\oedo!J Scramai 41\ 0 wanita mcngandung (bcrusia di antara 17 dan t\X t<llnrrl ), cla ri 
trir ncstcr ::;1tu lringga trimes ter tiga, yang mcnghadiri klinik ibu rncngandung dr llospital 
~~ola l~har tr Kclantan , disaring un tuk jangkitan kuman Chlnmydw trochonwt1s Sapuan dari 
c!1dm.crvrk diarnbilu nt1 rk diuji mcnggunakan tcknik Direct Fluoresce nt J\ntigc r1 
Keputuson: Daripada 440 wanita mengandung yang diuji, scramai cmpat orang disahkan 
mcngalami jangkitan ini , rncmberikan kadar j angkitan scbanyak 0.9%. Pcrbandingan 
stati stik tidak dapat dilakukan di antara mcreka yang positif dan negatif Jari scgi umur, 
bilangan kandungan, bil angan anak, status sosioekonom i, tahap pcrscko lahan, dan j uga 
scjarah kclahi ran prarnatang atau kcguguran, discbabkan bilangan lllercka y<.lllg positif 
X 
adalah kecil. Semua cmpat wanita yang dijangkiti kuman tm tidak mcmpunyai sebarang 
simptom, mcreka dibcri rawatan dan UJtan sclcpas rawatan menunjukkan mereka sembuh 
.~ sepenuhnya. Walaubagaimanapun, bilangan mcreka yang scdikit menghalang analisis 
statistik setcrusnya . 
· !, :l _., . 
Konk/usi: Disebabkan kadar jangkitan ( ·.rrochomatis di kalangan wan ita mengandt.m~ di 
Hospital Kola Bharu rcnclah, maka sanngan universa l ada lah tidak kos-cfektif, d<111 uji an 
di,~g,nostik berdasarka11 s imptom klinikal adalah tidak mencuk~p i. 
I : 
l: 
J 
XI 
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ABSTRACTS 
( .'h/amydia trachoma/is infection is the most common curable bacterial infection, and is 
now the most common sexually transmitted disease worldwide. World Health Organisation . 
fi gures estimated that 89 million new cases of geni tal chlamydia! infections· occur.rea;,'in 
1995, high ligh ting the worldwide prevalence of infections and the economic hurd.en .on 
hcarthcare delivery. For pregnant women, thi s infection has been associated with morbidity 
l()r both the mother and the newborn. 
I • 
Oh;ectives: This study was undertaken with the objectives to detennine the prevalence of 
_ge nit<tl Chlamydia trachomatis inrection in pregnancy among the attendees of Antenatal 
Clinic of ll ospi ta l Kota Bhant. Ke lantan so as to ascena in ,,·hether universa l screening is 
needed or not. The other objective is to observe the c!Tccti vencss of treatment or 
chlamydia! infection with one-week course of erythromycin steartltc SOOmg qid . 
Methodology 44 0 pregnant women (age rang~ 17 to 48 years old), in the li rst to thi rd 
ltllllester, attending the antenatal clinic of llospital Kota 11haru, Ke lantan were tested for 
( "/ilamydw trachoma fl s . Endocervical swabs were colkctcd fo r ( "hlamydia trac!Jo111ut1.\ 
diagnosis by Direct f- luorescence antigen detection (DF A) technique. 
J?esu/ts: Out of 440 tested women, four were positive, giving the prevalence rate of 0.9%. 
No valid stati sti ca l analysis can be made with regards to the age, gravidity, parity, 
socioeconomic status, educat ion level, history of pr~maturity .or stillbirth or abortion 
XII 
... 
., .. :; 
between the positive and negative group because of ~he small number of wornen with 
positive results. All the four women with positive results were retested afler treatment and 
all of them were cleared. However, small numbt:;r of patients again, precludes further 
statistical analysis. 
·~ 
I 
·. ;-: :- , . . 
Conclusion: As the prevalence rate of genital Chlamydia trachoma/is infection in anty~:f~~l · · 
populat.ion of Hospital Kota B~1a~_i_~- -~~~ .. !_ow, there is no need for univer~~l scree~ing to 
detect this infection. All of the women with positive chlamxdial tests were asymptomatic. 
Ther~fore diagnostic testing based on clinical findings is unreliable. 
XIII 
. , ' .. .... 

INTRODUCTION OF THE STUDY 
'• .. 
.. 
. I 
Chlamydia trachoma/is infection is the most common curable bacterial infection, and is 
.. now the most common sexually transmitted disease worldwide (Macmillan et a/, 2000). 
·: 
World Health Organisation figures estimated that 89 million new cases of genital 
chlamydia! infections occurred in 1995, highlighting the worldwide prevaleJ!l.~.~ ... of 
:, 
infections and the economic burden on healthcare delivery (Williamson and Wyandt, 
200Qj. For pregnant women, this infection has been associ?ted with morbidity for both the 
mother and the newborn. ln United Kingdom, the prevalence rate was about ten percent for 
chlamyd ia (Underhill et of. 2003). The ri se in the incidence may reflect improved detection 
witri· new diagnostic techniques, but the ro le of changing sexual behaviour also important 
(Catchpole, 200 I). 
An tenata l and neonatal screeni ng for ch lamydia! infect ion is part of a general campaign to 
. 
prevent , or reduce the effect of maternal transmiss ion of the microbial agents capable of 
infect ing fetuses in utero or infants in the neonatal period. By identifying those at ri sks, it is 
possible to ensure thnt they received whatever remedial treatment available. The 
importance of screening programme in reduc ing the prevalence of genital chlamydia] 
infec tion is stressed by the fac t that major ity of infected persons are more or less 
asymptomati c thus it is not dealt with by the traditional diagnostic medical approach. The 
result of the United Kingdom pilot of screening for genital chlamydia! infect ion suggest 
that an opportunisti c approach is acceptable to professionals and public and can achieve 
high population coverage (Chief Medical Officers' Advisory Group, 1998). 
Evidence already exists that screenmg rs effective m controlling genital chlamydia! 
infection and in reducing the incidence of pdvic inflammatory disease. (Scholes c' / a /, 
~- i~lh~ r:vcntion lead to better l)utcomes fl)r .some perinatal ;md postparhun Cl) lllpl ication 
' 
~ 
· -. (tv1c.Millan ct a/ 1985; Schachter el a/ 1986;1\.yan ct a/ 1990; Rastogi et a/, lOOJ ).· . ! l !l . • ,. 
:, 
o l" ( .'hfmnydia/ rrm:humulis =-' JH.:ciiic:-111y in ~I!I I C il i'! l i-!] pnpll l rllit"ll l l!rtS been dt)ll~ , l1•..: 11cc : i;j ~ 
Ncotlntai Death (ENl~D) were dllc 1u prematurity, congenital ckfccts a.nd :-;epsts, ,,.l! ll the 
rrem:.1turi ty tor> in Lhe lt .s t In ye:.1r 2000, prematurity \vas the c0.use for 26 out of fitl y c:1ses 
of ENND. Likewise, in 200 I, with the to t ~-11 of I .-J 668 deliveries and Perin~1t~d Mortality 
R<1 tl: <1 l 25 p~r I 000 birth , prl:TTJ (I (IIrity rank ~.;d high~.;::;( by C(I\J~ing :w ou t of 70 C(l::;~::; of 
ENND and 2 out o r 25 cases or l .atc Ncn 11 atal Death (Dr MHM .latnil , Paediatric 
Department, Hospital KoLa Hharu; persona l communication). T his statistic s emphasized 
that further evaluation as for causes of prematurity is needed. 
Apart from the significant morbidity and mortality_ associated with prematurity, more 
· importantly is for the humanitarian and economic aspects, it ~ust be recognized that this 
long-tenn morbidity is potentially avoidable. Therefore, this study is also looking at the 
- 'genital chlamydia! infection as a possible ~ause of premature delivery in Hospital Kota 
... _ 
.. aparu. 
:, 
3 
A. MICROBIOLOGY OF CHLAMYDIA 
In general, chlamydiae are small spherical gram-negative bacteria. They have a diameter of 
'0.2 to 0.4 micron and act as obligate parasites by replicating. inside the cytoplasm of 
·: 
e~karyotic cells. Chlamydiae possess a metabolism deficient in energy production. They 
' 
have a unique biphasic life cycle, with two . morphologically and functionally (E~~ipct 
entities. The ext racellular form, re_~erred to as elementary body (EB), is the infec~i.o~.'s but 
metqbolically inactive form of the organism. The EB can s_urvive outside the host cells but 
. cannot replicate. After the EB is endocytosed by the host ce lls, it differentiates into a larger 
form ca ll ed reticulate body (RB) with in next six to eight hours. which undergoes 
repficat ion via binary fi ss ion, followed by release of chlamydia! progeny. The ce ll cycle is 
rela ti vely slow, requiring approximately 48 hours for completion. (McGregor J A, 1999). 
-
The precise mechanisms by which EBs attaches and gain entry into the host cells are 
largely unknown. Chl amyd ia has a maj or outer membrane protein. which can be found in 
al1 serotypes and has been employed as an tigen in the detection of the organism 
Chlomyd/{1 trachomati,\ is subdivided into disttnct serogroups on the basis of dt!h~ rences in 
thcm1o stable polysaccharide antigens. Clinically, the serogroups A, 8, and C primarily 
cause ocular diseases such as trachoma and conj unctivitis. In addi tion, the serogroups D, E, 
r, G, II , I, J and K are involved primarily in genital infections i.e. cerviciti s, urethritis, 
salpingitis, epididymitis as well as perihepatitis, inclusion conjunctivitis and lower 
respiratory tract infections (McGregor JA, 1999). 
4 
· .. ·: 
B. PREVALENCE AND CLINICAL ASPECTS OF CHLAMYDIAL INFECTION 
The majority of genital chlamydia! infection is found in the developing world, reflecting 
provision and access to health care, health-seeking behaviour and the distribution of the 
.. 
·~global population. With such varied distribution, the need for a programme to identify and 
·· treat this disease is important. 
. ~ ':I. . ., . 
Chlamydia! infection present unique problems for public health programs, as it is. largely 
clim-~ally si lent. If it is unrecognized and left untreated, not on ly the pathogens may remain 
infectious in the host for months and can be readily transmitted to sex partners, but .a~so the 
lon:g- term consequences of relvic inflammatory disease, ectopic rregnancy, and tubal 
( ·~ 
factor infertility arc especially detrimenta l. Therefore, early detect ion and treatment of 
.fhlamydial infec ti on in both women and men is critical. Most infections (60 percent to 80 
rcrce nt) among 'vomen are asymptomatic, but if it is sym ptomatic, it has n va riety of 
manifestation This includes urethriti s, in which patients may present with dysuria and 
uri ~1ary frequency~ cervica l inflammation where patients present with excess discharge or 
postcoital or in lt;J rnensirual bleeding, and clinically, there wi ll be conges ted, edcmatousi 
cervical ec topy with small fol licles or unexpected contact bleeding from endocervical 
canal. However, more often than not, there will be no abnormal signs (Shaw et al, 1997). 
Ascending infection may cause endometritis and more importantly is pelvic inflammatory 
disease, which may be acute, subacute or silent. Chlamydia is recognized to be associated 
with at least 50% of cases of acute PID in developed countries. It is also a more common 
cause of perihepatitis than is gonococcus (Shaw eta!, 1997). 
5 
.For pregnant women, this infection has been associated with morbidity for both 'the mother 
an~ the newborn. Pregnant women with cervical infection at the time of abortion or vaginal 
birth appear to be at an increased risk for post-abortal or postpartum endometritis or 
.~salpingitis, or both (Mardh et a/ 198 1: Wein et a/ 1990). In Hospita l Kota Bharu, for the 
:y~~r 1999, out of 5655 patients admitte.d to gynaecology ward, 36 cases were for 
- ' 
'··endometritis, 14 for puerperal pyrexia/sepsis and 262 cases were for abortion .. Ho~exer, 
: 
none of these cases were screened for chla mydia! infection. The presence of mucopu~ulent 
~~.::=-=-""-', 
ce~jcitis during pregnancy may indicate a n increased risk qf c hlamydia! infec tion and poor 
... 
obstetric outcome. However, this is not a usefu l screening tool for chlamydia! infection in 
prebrnant women (Nugent eta/ 1992 ). 
, , 
( -~ .. 
In men, Chlamy dia trachomatis causes a spectrum of sympto ms incl ude urethri tis, 
epididym iti s and conjuncti vitis Up to 50 percent of reported cases of non-gonoccoca l 
urethritis a nd 3 1% of cases of ac ute epididym itis a re caused by infec tion by Chlom\'(liu 
trl1chomatis. An estimated I % to 2 1% of a ll man are asymptomatic cn rrier of the in fection 
and may act as reservo ir for its spread (Shaw et a/. 1997). 
The preva lence of Chlamydia trachomatis infec tion vanes cons iderab ly in d ifferent 
popul ation. Independent ri sk factors that have been cons istently assoc iated with chla mydia! 
infection include young age, having more than o ne sexual partner, hav ing a new sexua l 
partner, lack of use of barrier contraceptive devices, and concurrent gonococcal infection 
(Black, 1997). 
6 
, 
Genital Chlamydia trachomatis infection in pregnancy is reported to be as high as fifty 
percent (Gyaneshwar et ul 1987). In Thai land, the prevalence ranges between 5.7 to () .8 % 
.:(Kilmarx 1996; Thongkrajai et a/ 1999). In ·Malaysia, a study by Ngcow el a / ( 1990) in 
Kuala Lumpur us ing a s ingle antigen indirect. immunoflourcscence test to detect chlamyc\ial 
antibody showed that the pregnant women and adolescents female has h ighe r ant iP.Rd,y · · 
prevalence than nonpregnant and older women 04 . ?'Yo fo r pregnant wome;1. vs 24.8% f-o r 
nonpregnant women; 25 .6% for gi rls aged II to 20 vs 7.5% ~or women aged 2 1-30 years) . 
Thercl'ore, there IS growtng cnncem <1 hout the <l SSOC IClt iOil or genital chlamycli <ll inl'ection 
a
11
((poor obstetric outcomes including stil lbirth, premature labour and premature delivery 
ami low birth weight (Rastogi et ul I 999). Itt The l)retcrm Prcdictiotl Study by At tdrc\v and 
colleagues (2000), the assoc iation or second-trimester ge ni tourinary chlamydia inl'cction 
and subsequen t spont<lneous prc tcrtn birth \\' li S stucliecl . The result showed that the 
genitourinaty C. trachomat1s inl'ection at 24 weeks' gestation was associated with a tvvo-
!'old to th ree-l'o lcl increased ri sk or subsequent spontaneous pretenn birth . 
lligh titre of Immunoglobulin c; antibody to ( .'h/amydw trachoma /is was associated with 
rcclllr<.;nt spontaneous abortion. The mec hanism may involve reactiva tion or latent 
chlamydia! infection, endometria l damage from a past chlamydia! infec tion , or an immune 
response to an cpitopc shared by a chlamydia! ami n fetal antigen (Witkin et a/, 1 <)92 ) 
Another study by Clemen et a/ ( I 995) showed that women with serologic evidence of 
Chlamydia trach oma/is infection were signi ficantly tnorc likely than seronegative women 
to have prctenn birtl1, an infan t wi th lower mc<l n birth weight and an infant with a lower 
mean gestational age at birth. 
7 
Another retrospective review of 530 maternal and jnfant records demonstrates 'significant 
morbidity in early infancy associated with perinatally acquired Chlamydia trachomatis 
_:[ infection (Guascino S, 2000). There is 50 to 70 % risk of transmission from an infected 
I . 
·"mother to the neonate during delivery (Shaw el a/, 1997) from the exposure to chlamydiae 
~~; •:.. -" 
the birth canal. Indeed, the infants may aspirate chlamydiae-containing secretions with 
.. ~&eir first breath. In prospective cohort studies, conjunctivitis developed in II per:cen1Jo,,44 
--~:-Percent (Preece el a!, 1989) of inf~?ts born to mothers with C. lrachoma~is infect.ion::· and 
pnell_monia developed in I I percent to 20 pei:cent of suc_h infants (Fromell et a/ 1979; 
-=Ha~merschlag eta/ 1979; Scahchter eta! 1986) during the first year of life. 
Sy!T1ptoms of conjunctivitis, which include discharge and swollen eyelids, usually develop 
within first ten days of life. Symptoms of pneumonia, including a progressive ly worsening 
cough and conges ti on, most often develop within three to six weeks of birth (Williamson 
and Wyandt, 2000). 
8 
C. TREATMENT 
'As this chlamydia! infection is curable, most complications associated with it in women 
arid their infants can be avoided by appropriate treatment. However, treatment is ofien not 
3~ 
initiated because the infections arc frequently asymptomatic. The identification of at risk 
patients and treatment of these patients is a practical clinical approach in the redt;ctidW,G't' 
• • I 
transmission and prevention o f complications. In fact , the Centre for Disease Control 
reco'rnmended routine screening and treatment of the high-risk obstetric patients (Centr_e for 
Disease Contro l and Prevention, 1998). 
( ·: 
Chlamydiae arc susceptible to antimicrobial agents that interfere with protein synthesis by 
- blocking the ribosomal func tions such as erythromycin and tetracyc line. 
TctracyclirJc has been the mainstay or treatment. The current Centers !or Disease Control 
an~l Prtve ntion (CDC) recommendation is oral doxycycline I OOmg tw1cc il day for seven 
days . For acute urpcr gcni t ~ l infection such as pelvic i11l1ammatory disl:aS l~ , i11 travt:_nous 
t htra py is neccssar y. 
The alternative to oral doxycycline is erythromycin, .usual ly recommended as ciythromycin 
base 500mg six-hourly for seven days. llowcvcr, erythromycin is associated with 
gastrointestinal side efTects resulting in unreliab le compliance. 
As mentioned earlier, the cell cycle of chlamydiae is relatively slow, thus relatively 
prolonged antimicrobial treatme nt is necessary to ensure clearance of' the infectious 
9 
· . . 
However, currently, a s ingle dose of Azithromycin IS the drug of choice for 
chlamydia! infection . 
1s a newer macrolide that was developed to overcome some of the 
-~h<_:?rtcomings of erythromycin such as intolerance, pharmacokinetics, and limit.ed . 
I 
r 
r 
antimicrobial s pectrum. Azithromycin (technically an azal idc) has a IS-membered · rin·~. 
====..,...7" 
which . . is derived from the insertion of an amino group into the erythromycin ring. 
_ Azi~i1~omycin has unique pharmacokinetics that give rise to prolonged ti ssue levels, which t 
I 
allow briefer duration of therapy (3 to 5 days) for most in fections and a single:c16sc f 
i 
.. 
regimen for treatment or chlamydia! STOs. Numerous studies have shO\.vn no significant II 
I 
! difference in the clinical effectiveness of a single 1-g dose of azi thromycin in comparison 
; 
wi th the standard regimen of 7 days or twice-daily orally administered doxycycline in the 
treatment o r C. rrachonwri.h1Ssociated STD in men and women, with cli ni ca l cflicacics 
rar}ging from 88 to I OO%.U nfortunately, at present , there are limited data on the usc of 
azithromycin in adolesce nt and in pregnancy (CDC, 1998: Miller and Martin , 2000). 
Ery thromycin has bccr1 recommended for pregnant women and for those whom tetracycl ine 
is contraindicated The recommended dose is erythromycin base 500mg orally four times a 
day for seven days. Erythromycin crosses the placental barrier and is present in matemal 
milk (Philipson 1973 ). Treatment of the sex partners is needed so as to prevent reinfection 
of the index patient. 
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Diagnosis of chlamydia! infection must be made primarily on clinical ground because 
laboratory methods are imperfect. 
-:.. -
I L ~ Microscopically, there are no completely reliable features that can be used to , di~~9.~e · 
. · chlamydia! infection on a smear. The cells may contain cytoplasmic vac~oles of._varying 
·~F=== 
sizes~ and nuclei showing prominent margination of chromatin. Typically, Chlamydia 
. . . -
tra~h~matis affect endocervical and squamous metaplasia cells. Features that are suggestive 
of chlamydial infection include cytoplasmic vacuoles which may contain minute bodies, 
and' follicular cervicitis i.e. abundance of lymphoid cells of mixed population including 
tingible body macrophage (McKee 1997). 
Having said that, a number of methods have been developed for detection of chlamydia! 
infection, which varies in sensitivity and specificity. No single method h2.s yet gained 
-
general acceptance (Beagley and Timms, 2000). The selection of a diagnostic test for 
detection of chlamydia! genita l in fection depends on availab ility, local expertise, and 
prevalence of Chlamydia trachoma/is in the test population. Cell cultures from cervical 
swabs are I 00 percent specific and approx imately 80 to 95 percent sensitive. Chlamydia.! 
culture from cervical swab specimens has an estimated sensitivity of 75 percent to 90 
percent and a specificity of I 00 pe rcent, but requires 2 to 3 days for a result (Taylor-
Robinson & Thomas B, 199 1 ). Cell culture, although be ing the most sensitive and the gold 
standard, it must be emphasized that success of culture depends strongly on adequacy of 
sampling and laboratory technique (Beagley and Timm~, 2000). lt is a lso too expensive in 
11 
noncndemic regions, time consuming and is not widely available, so the usc of non-culture 
techniques is very attractive. The other techniques include antigen detection, nucleic acid 
' obcs cytology and serology (McGregor 1989) . 
. pr , 
common techniques for antigen detection are enzyme Immunoassay (Elf.) and · . · 
·!,:1. · '' ' 
antigen detection technique (DFA), the latter is used in ·Hospital · !<dta 
11haru. The time needed to obtain a result in DFA testing is abo ut half an hour, and the 
tim.~ ·needed for an ELISA result is 3 to 5 hours. DFA employs tluorescenf-labeled 
monoclonal antibody against major ou ter membrane proteins, which present ii1-·all 
.. 
chlamydia! se ro vars and throughout their life cycle. The sensitivity of DF/\ tes ting is 70 
percent to 95 percent, and it s speci fi city is 85 percent to 99 percent when compared with 
culture of cervical and urethral specimens taken from women (Stamm et a/ 1984; Baselski 
c·t (1/ 1987 ; Taylor-Robinson and Thomas, 1991 ). According to the Internal evaluation of 
thG. company, the test ki t used in Hosp ital Kota Bharu (Chlamydia-Cel IF Test, Ccl labs, 
1\ust.ralia) has sensitivity of almost I 00% <mel specificity of 99.5%. 
Poly111crasc chain rcac:tion (PCR) testing of cervical spccllllcns taken from women is 95 
percent to I 00 percent sens itive and almost 100 percent specific. DNA probes arc about 95 
percent sensitive and 98 percent to I 00 percent spedfi c when compared with culture . The 
result s of DNA probes may be ava ilable within 2 to 4 hours, and, like ELl S/\, the technique 
can he used for large volumes of samples. However, the usc of this method is currently 
limited because of its high cost (Starry et a/ 1997). Recently, testing the first vo id urine 
specimens with polymerase chain reaction and ligase chain reaction has shown that the 
12 
.. 
plification tests are as sensitive as tests with endocervical swabs cultures' (Guascino, 
, The problem with the antigen testing is tha,t, even after the bacteria were killed antigenic 
•; 
l chl~mydial particles may persist. Therefore, test of cure with antigen detection system, such 
' 
' ~ ·as inunw10flourescent antibody tests (IFA) may appear falsely positive even afte.r etf7tct,i.ve 
treatment. Alternatively, incompletely treate~ chlamydia may remain viable, alloVri~g for 
'·:' .. . 
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OBJECTIVES 
·.· 
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·~ .... ' .. 
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,. 
.. oBJECflVES 
·:primary objectives: 
To determine the prevalence of gen ita I Chlamydia trachomat 1s in fec,tion . in 
' ' t:l. If 
pregnancy amonb the attendees or Antenatal Clinic of Hospital Kota 13haru , Kelan tan. 
To observe the elfecti veness of the treatment of chlamydia! in!Cction with a \'ieek 
course or hythromycin Stearate S00 111 g six hourly. 
': 
Sc(ondary objcrtiYcs: 
genital clll ;tlnydl ,d lil fect iOll 
2 To ;l'>ses:; the outcomes or pn.:gnancy or the studied women 
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( ·~ . 0 METHODOLOGY 
,, . 
.. 
i. §_tudy population 
This is a hospital -based cross sectional study, 1n which consecutive wornen attending the 
Antenata l C linic of Hospital Kota Bharu between I st A ugust 200 I and 30 111 June 200~: ~~,crc 
. invited to part ic i pa te in the study (Appendi x I: flow chart o f chl amydia study). Part ic i.pants 
volunteered by signing informed consent form (Appendix 5: Information shee t and consen t 
form ). T he study populatio n included both the symptomatic and asymptomatic women. 
r;·iicnts receivi ng ant ib iotics. either s ~·s tern i c or local , i n the preced ing four \\'Cds were 
excluded from the study so as to minimize the possibility or fal se ncga ti\C results Those 
wi th scverc IJ,·pcrtc nsion or other medical illm:sscs. t h o~c '' ith pi:~L"cnta pr:1C\·i<l or 
mult ilcta l gc<;ta tion wen.: Cl lso exc luded from the :>tudy ill v iew nf' the po'\S th i lli\ ur c~rh· 
biases Ill the Ol lt CO IIll' o!' the prC t! ll~lflC )' 
Patient ' s refusa l IS the most 1111portan t excl usion c ritcnon because pati ent s r h:~d tt.; <.. !Pr 1 rhc 0 
consen t f()rm 111 or<.}cr lo be Included in the study 
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ii. ~~a'!..!m~p~l c~c.=.o,;:..;;ll~c .... ct_i_o_n 
" c,ach study subject, endocervica l swa.b is taken usrng a cotton -tipped swab and 
,.From 
sr;Jcared onto glass slide, air-dried and fixed in methano l, and are sent to the M icrobio logy 
laboratory of Hospital Kota Bharu for the diagnosis (Appendix 3: sample collection). 
O nce _ screening had taken place, the pat icnt · s name, hosp1ta I registration number, date or 
bi,:t h·, da te of screen ing were documented on a recruitment sheet Each woman . was 
interviewed according to <I detai led ~tandardizcd quest ionnaire lo r cl inical and obstetric 
his;o.ry. Data recorded lllc lude hiStUI)' or preVIOUS pregnancy, gravidity. pan ty and 
~:-.· 111 pto1ns of lower genital trac t in l'cct1on. 1f'any (Appendix~ : recru itment sheet) 
1 bt;1 on obstetric gestational age \\'dS based on th<.: doctors· best cstilllat ion, us1ng a 
COIIlblll<lt ion of' phys ica l exa1111natlnll , ultrasonography and \\.Olllall . S report:; f) I the date of' 
hci last lllenstru;d r criod ( I .M P) . 
The chosen patients then will l>e followed up until dcll vt: l y . Those w rth pOSitive results 
were trea ted v.-ith oral erythromyc ir1 :-.tcarate 500mg o.;r:-; hourly f'or scvcr1 days atlU rcp ~..:a 1 
t<.:s t were done one week after completing treatment T hetr se.xual partn ers w ere treated '-'"ltl• 
oral doxycycl ine I OOmg dai ly lor one week bu t no repeat t ~s t done. 
The period of gestation at delivery, the birth weight and the birth complications were 
obtained from the del ivery book kept 111 the labour ward as wel l as the patients· case no tes 
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r d . · ·al swabs that arc taken will be smeared directly onto a glass slide and air-fbQ Cll ()CCI VIC< • 
·before being fi xed in methanol for fi ve min~ttes, and then air-dried again . The antigen 
. · sing Chlamydia-eel IF test (Cellabs, A ustralia). I t detec ts the elementary. 
::ftl~lt:~ClllOil IS ll ·•,:1. 
ics (extracellular form or ( ·.troclwma!IS}. The flourescein-label led monoclonal an tibody . 
d
. d . .
11
· 11s· t the maJ·or outer membrane protein is utilized lor antigenic detection 1rccte .. ,tg. . 
I. I I t . ·d 'll llllllll~.· /_() ciC!-'fCC CciSILIS ror b,·ltch an·,ll ys· l·s· . l: ..  acll-Mosl or th ~..: s rc es createc arc sore ' ·' ~ -
hatch '<!onsists or twenty to th irty sl ides. llt t.: si1Jcs are processed 111 batches so as to 
maximi1.c tl1 1..: use or positi ve control sl ide . 
The l;tiH . :kd ;ullillodics (about 25 nticrol.itre) arc appl ied d1rcc tly to the lixed specune11 
SJJlear_ ilild !hell inGtJbated C'lt Yl degree CelslllS Ill (I lllOISt cha r nl>~..:r ror JO minutes ill dark 
~..:n v ll ()J.IJ JI (; Il t .llt l: silclcs lhcn ;m.: rtll Scd gently Ill ,) b;llh or Phosph;llc Butler Sohii iOil 
scanm.:d w-. i11g a llttorc~;cencc n11 croscopt.: tuldcr otl tllll!lCrs1on ;1t x()OO-x I 000 magntlic <.J tion 
The extrace llular ~ lcmentary bodies appear as bright apple-green fluoresc;ent pmpomt , 
smooth-edge disc shaped bodies and can be seen agamsl a background of counterstained 
cells. A pos itive diagnosis is made w hen fixed stained specimens show at least 10 
ChJamydial bodies. J\ negative diagnosis is made w hen fixed Sta ined specimen IS rrcc from 
bodies· b t 11 · · · 
· u cc s arc present, 1.c. one or more o! columnar endocervical or 
17 
metaplastic cells, or the presence of more than hundred erythrocytes per high power 
· copr·c field The presence or this many erythrocytes could not be used to assess the 
m1cros · 
l
ee of columnar cells because the red ·blood cells masked the other cells present in the prcscr · 
PIC lrrcnularly shared fluorescent material that dill'ers from chlamyd ia! bodies sam . t- . • 
described above or flu oresces whi te, red or ye llow are regarded as negative as it rcr.~Sf~pts 
nonspecilic bindrn ):! 
.. 
As the collection o r the endocervica l swabs or specuncn for ( .'hlumydw trochomatls 
diagnosis arc done by doctors nlantllng the antenatal clinic, includ111!-! the prtmary 
(tivestigator, van ;1t1 011 111 spec i1ne11 quality is exreeted. So, in order to overcome poten ti al 
biases assoc iated wllh spcc in1cll qua lity, every slide is assessed f"o1 the presc11cc or 
- co lulllnar cells I C !"or ce llular adequacy. 
_rhcrc arc two tt:chah>logrsts rc<•d•n!; the sl ides, both arc equa lly expcricll c'·d <111d hl!\ C twcn 
1·11-chargc or the lllllllllllOllourcscclll lest Ill llosp ital Kola Bharu lor pas I l l!r;,>~ \H roll! ve:u :, 
read togct lt ~ r w1tli the pr intary in vcsti gal t> r. The sl ides that arc read <IS HH.:onclustve 01 
positive arc rc - cxa~n tne cl anrl con fi r mcd by the microbiologist (Dr Nurah;u1 Mantng) As \\'l' 
( 
arc foii O\ving the :>tr ic t criteria for posit iv ity, the linal resul ts arc tltcn lkc 1dcd as c1thc1 
positive or ncgat1 vc, w ithout any inconc lusive result. 
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. Statistical and data anal sis 
IV. 
·~ The statistical methods and tests were chosen based on recommendations from statisticians 
in the university. 
For the calculation or sample s ize, the fonnula used was a s ingle proportion tes t. With: the 
po\ycr of the study taken as 80%, and a probabi lity of less than 0.05 as level or statistica ll y 
s.i~r~iticant , this study needs a total o r 42 7 part icipants to make it statistica ll y significant , 
but considering the..: pOSSibi lity Of th OSC tha t fa iJecl tO be IOII O'vV-llp , \VC aimed !or- 500 
parti cipants . 
- For the data , it wi ll be analyzed by 1:1shcr exact test and Student t-test where appropriate , 
whi le the COilliHit c..: J proJ:,rrammc chnse n was Statis tical Package for Soci<~l Sciences (SPSS) 
vcrSIOil 11 .0. 
I <) 
• .. 
·, 
:, 
RESULTS 
'· 
.. 
'· 
RESULTS 
·~ 
:A total of 440 pregmmt women with age rang•ng !"rom 17 to 48 years old , in their fi rst to 
third trimester, attending the antenatal clinic of Hospital Kota Bharu, Kelantan betw.een _I " 
" 't : l. ,,. 
August 2001 and J I ~~ .I uly 2002 were recruited into the study (Table I). The parameter~ ·:i;1 
the ~~cruitment sheet were analyzed in terms or normal distribution, frequency and 
pcr.ccntage. 
/\s 'li>r the qualit y of the specimen. all o l" th~ slides '' ~ •-c judged to be adcq uate, that is, all 
of tilt: slides h:wc at least one columnar or metaplas ti c ce ll Because the criteria fo r 
j)ositivity arc l"o llowed stri ctl y, (i .e pos itive diat~nosis is made when lixed stai ned 
spcc1nH.:ns silo\\' at least I 0 chla•nydia l bodies " hich appc;u as bright apple-green 
lluorescent pinpoint, smooth-edg1; disc shaped bod1es), the final results arc decided <JS 
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l 'a blc 1: The age dis tribution of the s tudy population 
--- - -~ ------·- - - --. ·-
·: Mean 29 6l 
- - - - - -- --- ----- --
Std. Error of Mean 0 . .\08 
'•:' 
- -
- - . --- ·· -
-- --I Srd. Deviation () 452 I 
.. ---- --------- - - ~ - i 
-· Median i .1 0.00 ! 
I 
I 
I 
..... ----~-- - --
.. tvloclc .~0 
( : 
M i Ill mu rn 17 
- I ~ 
:q•,c 1s .?'J (> \ \\1111 '~landard deviat ion of f> :152 The 1nmk of age 1s 10 , \\ l11ch ru;, ·: tll: : te~; 
(, t1 'X> ( 2~ pati ents) of the studied population l'hc age is norm11lly distributed , !hal is 
,. 
consistent Wllh the normal population. 
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2 1·1 result of Chlamydia! test in pregnant women in Hospital Kota Dharu Table : IC 
-z -.... -- -- .. --
frequency Percent 
- -------------- ----- -- ---·-- --
Negati ve 
1 -
436 <)') . I 
Pos iti ve 4 ()C) I 
-·------i 
Tnt11l 440 I 
: 100.0 
I 
- .J. - -·- - . --
I : 
or the tJtlO women tested , lo ur had positi ve DF/\ test, giving the sample prC \'<lkllCC rate of 
() _() IH.:rccnl. l11 the ot her words, we arc 95% sure tlt;lt l ite prevalence of the ).!C illtal 
( "li!rJm_nlwtmchoJnott, 111 a11tcnatal populat ion wi ll be bct\\-t:en 0 2 to 2.1 percent !"he 05% 
7 ()) 
In VH.:w of the Slllall llllillbcr of women with positive chlalllyd•al test, no va hd von,pan son 
in terms of dc111ograph1c data ;md pregnan cy outcome bctwc~:n the posit ive and negati ve 
group o f women can be made, thus no statistica l analys1s attempted Subscqu~~ntly, the 
secondary obj ec tives arc not achieved. Therefore, these subsequent results are presented 
111 
tenns of frequency and percentage on ly . 
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Table l.l: Age range and chlamydia! test results 
Age in yca.rs - ~ 
-=-r==-==- - I 
I 
I 
- --· -·· I 
Total I 
I 
25 or lt:ss 
-
More than 2 5 
R csult 
Ncg<~ ti vc Positive 
I 
- - -· - · ·t · -
Tota l (%) 
The wo111 cn at 25 yea rs old or less represent 10.5 % of the study popula tion. The age cut o lr 
at 25 years old is 1ak cn as prc " iotts Slttd ics h;t,·e shown that those under 2:' were al hi gher 
risk of contracting ( "h!amrdw truclwmutl.\ ( 131ad 1 997 ~ CDC 1998 ). llowcv:.:r , 111 th is 
SWdy, 7)<X, or \\'OII ICII IV tlh pn ·~i l l\ ·e cltl alllyd t;til cSI <lrC lllore than 2 5 years or ; 1 1:~e 
Table J: Effectiveness of 1-wcek course of erythromycin s tearate for treatment of 
genital chlamydia! infection 
Prctr.tatmcnt result Post treatment result 
Posit ive Negative 
.. 
Posit ive Nega ti ve 
Positi ve Negat ive 
[>ositivc -- - - - - - - ·-----Negati ve 
I : 
All of the w omen with pOSiti ve results had been cleared of the infection with one-\\ eel.: 
- course of crytliro lll yc in s tea ra te 500 lil t! (>-hourly . l lowcvcr, the very small salllple size 
precludes f"urtiJcr Slat istica l (lllillySIS 
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